Menu

Britain Set to Become First Country to Approve Three-Parent IVF

Parliament voted to allow mitochondrial replacement therapy last year. This latest decision suggests we may see babies born from the technique in the country in 2017.

Dec 16, 2016
Joshua A. Krisch

PIXABAY, DRKONTOGIANNNIIVFOn Thursday (December 16), Britain’s Human Fertilisation and Embryology Authority agreed to approve mitochondrial replacement therapy in humans. The technique is informally known as “three-parent” in vitro fertilization (IVF), because it is intended to prevent genetic disorders by using DNA from the mother, the father, and a female mitochondrial donor.

“Mitochondrial donation offers a real opportunity to cure a class of potentially devastating inherited conditions and will bring hope to hundreds of affected families in the UK,” Dagan Wells, a professor at Oxford University, told Reuters. These inherited conditions include muscular dystrophy and organ failure.

Clinics in Britain will still need to apply to a governmental fertility regulator for permission to use the technique on a case-by-case basis, STAT News reported, but the move will still put Britain far ahead of the United States, where the procedure is still illegal. In September, U.S. doctors traveled to Mexico to test the technique, which produced the first baby from the three-parent IVF procedure.

Mary Herbert of Newcastle University told STAT that her hospital plans to apply for a license to use the technique, and is hoping to treat up to 25 patients per year. “It is enormously gratifying that our many years of research in this area can finally be applied to help families affected by these devastating diseases,” she said.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!